These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37404051)

  • 1. Structural Vulnerabilities in DLBCL for Enhanced Treatment Strategies.
    Cristaldi V; Lund AW
    Cancer Res; 2023 Aug; 83(16):2643-2644. PubMed ID: 37404051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.
    Apollonio B; Spada F; Petrov N; Cozzetto D; Papazoglou D; Jarvis P; Kannambath S; Terranova-Barberio M; Amini RM; Enblad G; Graham C; Benjamin R; Phillips E; Ellis R; Nuamah R; Saqi M; Calado DP; Rosenquist R; Sutton LA; Salisbury J; Zacharioudakis G; Vardi A; Hagner PR; Gandhi AK; Bacac M; Claus C; Umana P; Jarrett RF; Klein C; Deutsch A; Ramsay AG
    J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37219943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma.
    Lin AY; Gordon LI
    J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37395274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
    Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic virus oHSV2 combined with PD-1/PD-L1 inhibitors exert antitumor activity by mediating CD4 + T and CD8 + T cell infiltration in the lymphoma tumor microenvironment.
    Zhang J; Guo Y; Fang H; Guo X; Zhao L
    Autoimmunity; 2023 Dec; 56(1):2259126. PubMed ID: 37736847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
    Keane C; Vari F; Hertzberg M; Cao KA; Green MR; Han E; Seymour JF; Hicks RJ; Gill D; Crooks P; Gould C; Jones K; Griffiths LR; Talaulikar D; Jain S; Tobin J; Gandhi MK
    Lancet Haematol; 2015 Oct; 2(10):e445-55. PubMed ID: 26686046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients.
    Liu Y; Guo X; Zhan L; Wang L; Wang X; Jiang M
    Comput Math Methods Med; 2021; 2021():4468140. PubMed ID: 34422089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
    Xu-Monette ZY; Xiao M; Au Q; Padmanabhan R; Xu B; Hoe N; Rodríguez-Perales S; Torres-Ruiz R; Manyam GC; Visco C; Miao Y; Tan X; Zhang H; Tzankov A; Wang J; Dybkær K; Tam W; You H; Bhagat G; Hsi ED; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; van Krieken JH; Winter JN; Westin JR; Pham LV; Medeiros LJ; Rassidakis GZ; Li Y; Freeman GJ; Young KH
    Cancer Immunol Res; 2019 Apr; 7(4):644-657. PubMed ID: 30745366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
    Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
    Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8
    Xu Y; Liu Z; Lv L; Li P; Xiu B; Qian W; Liang A
    J Exp Clin Cancer Res; 2020 Nov; 39(1):238. PubMed ID: 33168024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone.
    Rajnai H; Heyning FH; Koens L; Sebestyén A; Andrikovics H; Hogendoorn PC; Matolcsy A; Szepesi Á
    Virchows Arch; 2014 Feb; 464(2):229-39. PubMed ID: 24306958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4
    Liu G; Luan J; Li Q
    DNA Cell Biol; 2016 Dec; 35(12):845-852. PubMed ID: 27704876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma.
    Wang J; Wang Y; Wan L; Chen X; Zhang H; Yang S; Zhong L
    Front Immunol; 2023; 14():1230017. PubMed ID: 37790933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.
    Xu-Monette ZY; Wei L; Fang X; Au Q; Nunns H; Nagy M; Tzankov A; Zhu F; Visco C; Bhagat G; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Sun X; Han X; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Li Y; Xu B; Albitar M; You H; Young KH
    Clin Cancer Res; 2022 Mar; 28(5):972-983. PubMed ID: 34980601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR5
    Tang J; Zha J; Guo X; Shi P; Xu B
    Int Immunopharmacol; 2017 Sep; 50():146-151. PubMed ID: 28662433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Wang M; Wang B; Fang W
    J Clin Pharm Ther; 2021 Jun; 46(3):832-837. PubMed ID: 33569786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
    Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
    J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of AP2M1 correlates with worse prognosis by regulating immune microenvironment and drug resistance to R-CHOP in diffuse large B cell lymphoma.
    Liu X; Zhao X; Yang J; Wang H; Piao Y; Wang L
    Eur J Haematol; 2023 Feb; 110(2):198-208. PubMed ID: 36335584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.